Six-month safety evaluation of robenacoxib tablets (Onsior™) in dogs after daily oral administrations

about

Six-month safety evaluation of robenacoxib tablets (Onsior™) in dogs after daily oral administrations

Item

http://www.wikidata.org/entity/Q58770742

description

im August 2018 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 17 August 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2018

@uk

name

Six-month safety evaluation of ...... ter daily oral administrations

@en

Six-month safety evaluation of robenacoxib tablets

@nl

type

Item

label

Six-month safety evaluation of ...... ter daily oral administrations

@en

Six-month safety evaluation of robenacoxib tablets

@nl

prefLabel

Six-month safety evaluation of ...... ter daily oral administrations

@en

Six-month safety evaluation of robenacoxib tablets

@nl

P1476

Six-month safety evaluation of ...... ter daily oral administrations

@en

P2093

Patrick Brossard

http://www.w3.org/2001/XMLSchema#string

Rainer Helbig

http://www.w3.org/2001/XMLSchema#string

Stephen B King

http://www.w3.org/2001/XMLSchema#string

P2860

Systematic review of nonsteroidal anti-inflammatory drug-induced adverse effects in dogs

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial

Toxicology of frequently encountered nonsteroidal anti-inflammatory drugs in dogs and cats.

Efficacy and safety of firocoxib in the management of canine osteoarthritis under field conditions.

Preclinical pharmacology of robenacoxib: a novel selective inhibitor of cyclooxygenase-2.

Analytical determination and pharmacokinetics of robenacoxib in the dog.

Safety and tolerability of 3-week and 6-month dosing of Deramaxx (deracoxib) chewable tablets in dogs.

Analgesic and anti-inflammatory actions of robenacoxib in acute joint inflammation in dog.

Tolerance of firocoxib in dogs with osteoarthritis during 90 days.

P2888

s12917-018-1566-1

P304

242

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12917-018-1566-1

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Céline E Toutain

P577

2018-08-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1106156045

http://www.w3.org/2001/XMLSchema#string

P698

30119677

http://www.w3.org/2001/XMLSchema#string

P932

6098579

http://www.w3.org/2001/XMLSchema#string